(Reuters) – South Africa’s Illovo Sugar said on Monday it has received a non-binding expression of interest from its largest shareholder Associated British Foods in buying the rest of the company.
AB Foods, which holds a 51.35 percent stake in Illovo, intends to make an offer of 20 rand ($1.24) per share for the stake it does not yet hold, Africa’s top sugar producer said in a statement, in a deal worth around 4.1 billion rand ($253 million).
Illovo’s shares were up 9.42 percent at 20.10 rand by 1429 GMT, hitting a 10-month high, while ABF’s shares were down 1.16 percent at 3,061 pence.
Illovo, which has been cutting costs to survive low sugar prices, said ABF plans to make a cash offer to all other shareholders but there was no certainty of a deal.
“Illovo certainly faces challenges, no doubt about that, but these are not new challenges,” said ABF’s finance director John Bason, referring to the drought sweeping across southern Africa. “We take a long term view.”
Shares in the South African company have been depressed by the effects of the severe drought in its home market, Standard Bank Group Securities analyst Sumil Seeraj told Reuters.
“It is opportune for ABF to make the offer now and I think it is a bit low,” said Seeraj.
Seeraj expects some of the sugar producer’s other large shareholders would demand a higher premium as South Africa’s weaker rand could boost Illovo’s earnings this year. ($1 = 16.1979 rand) (Reporting by TJ Strydom and Tiisetso Motsoeneng; Editing by James Macharia, Greg Mahlich)
The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.
The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.
Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.